Page last updated: 2024-08-24

dexmedetomidine and Visceral Pain

dexmedetomidine has been researched along with Visceral Pain in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Li, J; Tang, H; Tu, W1
Jiang, YM; Li, WW; Liu, YN; Shi, R; Wang, ZW; Zheng, B1
Feng, J; Lan, J; Peng, W; Zheng, J1
Bao, C; Chen, Z; Jiang, Z; Song, Q; Wang, H; Zhou, G1
Sun, C; Sun, L; Zhou, J1
Feng, M; Liang, M; Qiu, Y; Shao, A; Tang, X; Wang, J1

Trials

1 trial(s) available for dexmedetomidine and Visceral Pain

ArticleYear
Effect of Intravenous Oxycodone in Combination With Different Doses of Dexmedetomdine on Sleep Quality and Visceral Pain in Patients After Abdominal Surgery: A Randomized Study.
    The Clinical journal of pain, 2018, Volume: 34, Issue:12

    Topics: Abdomen; Administration, Intravenous; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Dexmedetomidine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oxycodone; Pain Management; Pain, Postoperative; Sleep; Treatment Outcome; Visceral Pain

2018

Other Studies

5 other study(ies) available for dexmedetomidine and Visceral Pain

ArticleYear
Mechanism of dexmedetomidine preconditioning on spinal cord analgesia in rats with functional chronic visceral pain.
    Acta cirurgica brasileira, 2022, Volume: 37, Issue:2

    Topics: Analgesia; Animals; Chronic Pain; Dexmedetomidine; Rats; Rats, Sprague-Dawley; Spinal Cord; Toll-Like Receptor 4; Visceral Pain

2022
Patient-controlled intravenous administration of dexmedetomidine with nalbuphine versus sufentanil for post cesarean delivery analgesia: A retrospective observational study.
    The Kaohsiung journal of medical sciences, 2023, Volume: 39, Issue:7

    Topics: Administration, Intravenous; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Cesarean Section; Dexmedetomidine; Female; Humans; Nalbuphine; Pain, Postoperative; Pregnancy; Sufentanil; Visceral Pain

2023
Nrf2 mediates the antinociceptive activity of dexmedetomidine in an acute inflammatory visceral pain rat model by activating the NF-κB sensor.
    Cell biochemistry and function, 2020, Volume: 38, Issue:1

    Topics: Acute Disease; Analgesics; Animals; Dexmedetomidine; Disease Models, Animal; Inflammation; Male; NF-E2-Related Factor 2; NF-kappa B; Nociception; Rats; Rats, Sprague-Dawley; Visceral Pain

2020
MicroRNA-211-5p Enhances Analgesic Effect of Dexmedetomidine on Inflammatory Visceral Pain in Rats by Suppressing ERK Signaling.
    Journal of molecular neuroscience : MN, 2019, Volume: 68, Issue:1

    Topics: Analgesics, Non-Narcotic; Animals; Cytokines; Dexmedetomidine; Male; MAP Kinase Signaling System; MicroRNAs; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Rats; Rats, Sprague-Dawley; Visceral Pain

2019
MiR-34a affects dexmedetomidine-inhibited chronic inflammatory visceral pain by targeting to HDAC2.
    BMC anesthesiology, 2019, 07-19, Volume: 19, Issue:1

    Topics: 3' Untranslated Regions; Animals; Chronic Pain; Cytokines; Dexmedetomidine; Down-Regulation; Histone Deacetylase 2; Hypnotics and Sedatives; Male; Microarray Analysis; MicroRNAs; Pain Threshold; Polymerase Chain Reaction; Random Allocation; Rats, Sprague-Dawley; Reflex; Spinal Cord; Trinitrobenzenesulfonic Acid; Up-Regulation; Visceral Pain

2019